LifeSci Capital initiated coverage of Tourmaline Bio (TRML) with an Outperform rating and $58 price target
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TRML:
Education
About Us
Working with TipRanks
Follow Us
